Clinical Study

Phase II Trial Of Smo/Akt/Nf2 Inhibitors In Progressive Meningiomas With Smo/Akt/Nf2 Mutations

Posted Date: May 15, 2019

  • Investigator: Rekha Chaudhary
  • Specialties:
  • Type of Study: Drug

The purpose of this study is to test good and bad effects of these two different drugs against meningioma tumors with altered genes. Today, therapy for meningioma is the same for all patients, and is not based on tumor genetic testing. This trial is trying to see if tumor genetic testing would be he

Criteria:

To Be Eligible To Participate, Patients Must Have A Meningioma Which Has Gotten Bigger Or Grew Back

Keywords:

A071401, Cancer, Brain, Smo/Akt/Nf2 Mutation, Meningioma

For More Information:

Uc Cancer Institute
513-584-7698
kastla@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.